0001179110-20-011522.txt : 20201202
0001179110-20-011522.hdr.sgml : 20201202
20201202062352
ACCESSION NUMBER: 0001179110-20-011522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201130
FILED AS OF DATE: 20201202
DATE AS OF CHANGE: 20201202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carmona Jose
CENTRAL INDEX KEY: 0001693612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 201362352
MAIL ADDRESS:
STREET 1: C/O INNOCOLL HOLDINGS PLC
STREET 2: 3803 WEST CHESTER PIKE
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2020-11-30
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001693612
Carmona Jose
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY ST., SUITE 300
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
6.27
2020-11-30
4
A
0
400000
0
A
2030-11-29
Common Stock
400000
400000
D
25% of this option shall vest on October 1, 2021, then in 12 equal quarterly installments thereafter.
/s/ Joanne M. Protano, Attorney-in-Fact
2020-12-02